KPP
IRMD icon

Kings Path Partners’s iRadimed IRMD Stock Holding History

Kings Path Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$654K Hold
6,840
– – 0.17% 51
2026
Q1 		$665K Hold
6,840
– – 0.23% 45
2025
Q4 		$665K Hold
6,840
– – 0.23% 45
2025
Q3 		$487K Sell
6,840
-5,525
-45% -$368K 0.18% 56
2025
Q2 		$739K Hold
12,365
– – 0.3% 40
2025
Q1 		$649K Sell
12,365
-12,205
-50% -$686K 0.32% 49
2024
Q4 		$1.35M Hold
24,570
– – 0.58% 37
2024
Q3 		$1.24M Buy
24,570
+562
+2% +$25.9K 0.52% 45
2024
Q2 		$1.05M Buy
+24,008
New +$1.02M 0.5% 51

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Kings Path Partners's IRMD Position: Q2 2026 in Review

Kings Path Partners held its iRadimed (IRMD) position steady in Q2 2026 at 6,840 shares worth $654K. The position accounts for 0.17% of the portfolio, ranked #51.

Kings Path Partners first reported a position in IRMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.35M in Q4 2024. 22 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Kings Path Partners held 6,840 shares of iRadimed worth $654K as of Q2 2026.
  • Kings Path Partners left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up 0.17% of Kings Path Partners's portfolio in Q2 2026, its #51 holding.
  • Kings Path Partners first reported a position in iRadimed in Q2 2024 and has held it in 9 quarters since.
  • Kings Path Partners's iRadimed position peaked at $1.35M in Q4 2024.
  • 22 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.